Balyasny Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.97M Buy
+312,982
New +$7.48M 0.01% 1206
2025
Q2
Hold
0
2745
2025
Q1
Sell
-396,922
Closed -$7.21M 2733
2024
Q4
$7.28M Sell
396,922
-727,650
-65% -$11.7M 0.02% 1105
2024
Q3
$17.3M Buy
1,124,572
+352,426
+46% +$5.88M 0.04% 705
2024
Q2
$12.5M Buy
+772,146
New +$12.5M 0.03% 785
2024
Q1
Sell
-300,875
Closed -$9.42M 2558
2023
Q4
$9.42M Buy
300,875
+284,557
+1,744% +$6.8M 0.03% 891
2023
Q3
$340K Buy
+16,318
New +$443K ﹤0.01% 1867
2023
Q1
Sell
-2,578
Closed -$41K 2577
2022
Q4
$41K Buy
+2,578
New +$40.3K ﹤0.01% 2374
2022
Q3
Sell
-10,390
Closed -$146K 2805
2022
Q2
$146K Buy
+10,390
New +$194K ﹤0.01% 2236
2022
Q1
Sell
-85,687
Closed -$2M 2429
2021
Q4
$2M Sell
85,687
-43,291
-34% -$871K 0.01% 1212
2021
Q3
$2.14M Buy
+128,978
New +$2.49M 0.01% 1103
2020
Q4
Sell
-67,864
Closed -$2.8M 1270
2020
Q3
$2.8M Buy
67,864
+60,072
+771% +$2.59M 0.03% 752
2020
Q2
$378K Buy
+7,792
New +$374K ﹤0.01% 965
2019
Q1
Sell
-78,845
Closed -$1.27M 1368
2018
Q4
$1.27M Sell
78,845
-1,177,231
-94% -$22.9M 0.01% 830
2018
Q3
$26.1M Buy
1,256,076
+1,173,483
+1,421% +$18.5M 0.14% 240
2018
Q2
$1.26M Buy
+82,593
New +$1.47M 0.01% 1067
2018
Q1
Sell
-357,958
Closed -$9.91M 1892
2017
Q4
$10.8M Buy
+357,958
New +$11.4M 0.04% 614
2017
Q3
Sell
-141,745
Closed -$3.95M 1837
2017
Q2
$3.95M Buy
+141,745
New +$4.22M 0.02% 806
2017
Q1
Sell
-432,691
Closed -$12.5M 1560
2016
Q4
$12.5M Buy
+432,691
New +$11.4M 0.08% 414
2016
Q2
Hold
0
1131
2016
Q1
Hold
0
1241

Other funds holding ACAD